Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
University Hospital Olomouc (FNOL) is one of the largest and most advanced healthcare and clinical research institutions in the Czech Republic. Serving as the primary teaching hospital for Palacký University, it provides comprehensive medical care across nearly all specialties, with particular expertise in hemato-oncology, cardiology, and neurosciences. The institution is a major hub for international clinical trials, participating in numerous Phase I-IV studies in collaboration with global pharmaceutical and biotech companies. FNOL integrates cutting-edge medical technology with academic research, operating specialized centers for advanced cell therapies and molecular medicine. Its role as a leading regional provider and a research powerhouse makes it a critical entity in the Central European life sciences ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on University Hospital Olomouc.